| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.74B | 3.64B | 3.43B | 3.01B | 2.19B | 834.20M |
| Gross Profit | 1.17B | 1.13B | 1.62B | 1.25B | 606.80M | -101.90M |
| EBITDA | 681.70M | 516.30M | 607.50M | 502.70M | 369.90M | -105.80M |
| Net Income | -29.10M | -74.40M | 27.40M | 8.10M | -10.20M | -357.30M |
Balance Sheet | ||||||
| Total Assets | 3.40B | 3.42B | 3.17B | 2.90B | 2.83B | 3.18B |
| Cash, Cash Equivalents and Short-Term Investments | 240.70M | 342.00M | 254.80M | 303.30M | 543.60M | 773.60M |
| Total Debt | 2.34B | 2.16B | 1.94B | 1.72B | 1.69B | 2.25B |
| Total Liabilities | 3.20B | 3.16B | 2.79B | 2.58B | 2.52B | 2.87B |
| Stockholders Equity | 6.40M | 82.10M | 227.20M | 226.20M | 225.00M | 240.30M |
Cash Flow | ||||||
| Free Cash Flow | 484.70M | 487.10M | 269.40M | 236.20M | 236.40M | 25.00M |
| Operating Cash Flow | 692.30M | 711.90M | 566.50M | 478.70M | 396.00M | 99.60M |
| Investing Cash Flow | -224.90M | -240.80M | -413.90M | -264.90M | -150.30M | -69.90M |
| Financing Cash Flow | -426.20M | -378.50M | -187.00M | -440.70M | -490.30M | 564.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £356.19M | 17.87 | 4.99% | 2.81% | 6.94% | 9.13% | |
66 Neutral | £303.77M | 4.07 | 9.30% | ― | -0.52% | 68.53% | |
65 Neutral | £1.39B | 7.62 | 6.41% | ― | 2.96% | 9.30% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | £710.55M | 12.23 | -68.82% | 6.46% | 3.15% | -34.09% | |
55 Neutral | £634.88M | 11.98 | 15.81% | 1.50% | 5.39% | -3.64% | |
50 Neutral | £1.29B | -45.75 | -65.76% | 2.50% | 4.58% | -24.15% |